BSE Live
Oct 29, 16:01Prev. Close
442.15
Open Price
447.20
Bid Price (Qty.)
442.70 (1)
Offer Price (Qty.)
443.90 (10)
NSE Live
Oct 29, 15:18Prev. Close
441.85
Open Price
442.80
Bid Price (Qty.)
442.55 (2)
Offer Price (Qty.)
443.90 (63)
| Profit & Loss account of Panacea Biotec (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 155.17 | 95.73 | 181.84 | 521.91 | 620.02 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.26 | 13.94 | 0.36 | |
| Revenue From Operations [Net] | 155.17 | 95.73 | 181.57 | 507.97 | 619.66 | |
| Total Operating Revenues | 158.09 | 96.21 | 183.72 | 530.09 | 646.90 | |
| Other Income | 30.88 | 3.53 | 12.50 | 53.66 | 25.56 | |
| Total Revenue | 188.96 | 99.74 | 196.22 | 583.75 | 672.46 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 75.27 | 59.13 | 92.05 | 157.01 | 168.82 | |
| Purchase Of Stock-In Trade | 11.44 | 0.00 | 0.00 | 21.62 | 24.02 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -28.18 | 17.30 | -3.97 | -9.80 | 21.51 | |
| Employee Benefit Expenses | 46.64 | 41.16 | 35.97 | 132.21 | 139.80 | |
| Finance Costs | 5.27 | 104.63 | 103.23 | 103.50 | 115.00 | |
| Depreciation And Amortisation Expenses | 26.91 | 33.03 | 33.69 | 66.15 | 71.32 | |
| Other Expenses | 115.15 | 125.29 | 67.77 | 159.56 | 180.24 | |
| Total Expenses | 252.49 | 380.54 | 328.74 | 630.25 | 720.71 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -63.53 | -280.80 | -132.53 | -46.50 | -48.25 | |
| Exceptional Items | -15.40 | 313.35 | 0.00 | -37.54 | 49.65 | |
| Profit/Loss Before Tax | -78.93 | 32.55 | -132.53 | -84.04 | 1.40 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 39.88 | 7.48 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.98 | |
| Deferred Tax | -22.78 | 3.13 | 10.64 | -11.38 | 0.00 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 1.51 | |
| Total Tax Expenses | 17.10 | 10.61 | 10.64 | -11.38 | 0.53 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -96.02 | 21.94 | -143.17 | -72.66 | 0.87 | |
| Profit/Loss From Continuing Operations | -96.02 | 21.94 | -143.17 | -72.66 | 0.87 | |
| Profit/Loss For The Period | -153.07 | 26.57 | -71.88 | -72.66 | 0.87 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -24.99 | 4.34 | -11.73 | -11.86 | 0.14 | |
| Diluted EPS (Rs.) | -24.99 | 4.34 | -11.73 | -11.86 | 0.14 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 63.15 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 105.67 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 1.67 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 14.77 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y